Treatment effect heterogeneity is of a great concern when evaluating the treatment. However, even with a simple case of a binary treatment, the distribution of treatment effect is difficult to identify due to the fundamental limitation that we cannot observe both treated potential outcome and untreated potential outcome for a given individual. This paper assumes a finite mixture model on the potential outcomes and a vector of control covariates to address treatment endogeneity and imposes a Markov condition on the potential outcomes and covariates within each type to identify the treatment effect distribution. The mixture weights of the finite mixture model are consistently estimated with a nonnegative matrix factorization algorithm, thus allowing us to consistently estimate the component distribution parameters, including ones for the treatment effect distribution.
No takes yet. Share an insight, caveat, or question.
Myungkou Shin (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: